http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8e9e9b8f87e99e40cdda745ae6b5391
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hayes |
| name | Daniel F Hayes Daniel F. Hayes |
| given-name | Daniel F Daniel F. |
| organization-name | a University of Michigan, Division of Hematology/Oncology, Ann Arbor, Michigan, USA; From the Division of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Pathology, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; and the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 1University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.; 2Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. From the Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN; Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD Case Western Reserve University, Cleveland, OH; American Society of Clinical Oncology, Alexandria, VA; National Cancer Institute, Bethesda, MD; and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI 1Breast Cancer Program, Departments of; 2Oncology, Authors' Affiliations: 1Department of Pathology, Saint Barnabas Medical Center, Livingston, New Jersey; 2Department of Pathology, University of Colorado, Denver, Colorado; 3Institute of Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, 4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; 5Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham, North Carolina; 6Department of Pathology, Mount Sinai Medical Center; 7Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York; 8Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 9Department of Medical Oncology, The Angeles Clinic and Research Institute, Santa Monica, California; 10Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota; 11Department of Medical Oncology, University of California, San Francisco, California; 12Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts; 13Department o From the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA; Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC. 4Clinical Director, Breast Oncology Program, Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.; 5Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. Stuart B. Padnos Professor of Breast Cancer Research, University of Michigan Rogel Cancer Center, Ann Arbor, MI Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, USA The University of Michigan, Ann Arbor (Hayes) University of Michigan Rogel Cancer Center, Ann Arbor, MI Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, University of Michigan, Ann Arbor, Michigan N. Lynn Henry, Jill Hayden, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Faouzi Azzouz, Zereunesay Desta, Lang Li, Anne T. Nguyen, Suzanne Lemler, and David A. Flockhart, Indiana University School of Medicine; Anna Maria Storniolo, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; and Karineh Tarpinian, Elizabeth Yakim, and Vered Stearns, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD. Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland... University of Michigan, Ann Arbor, MI Authors' Affiliations: 1University of Rochester Medical Center, Rochester, New York; 2Boston University Medical Center, Boston, Massachusetts; 3University of Texas, San Antonio, Texas; 4University of Colorado Denver, Aurora, Colorado; 5University of Michigan, Ann Arbor, Michigan; 6BrainLab, Munich, Germany; 7Varian Medical Systems Inc., Palo Alto, California; 8University of California Irvine, Orange, California; 9Karmanos Cancer Institute, Detroit, Michigan; 10Olathe Medical Center, Olathe, Kansas; 11Genzyme Corporation, Framingham, Massachusetts; 12Knight Cancer Institute, Oregon Health and Sciences University, Portland Oregon; 13National Cancer Institute, Rockville, Maryland; and 14Memorial Sloan-Kettering Cancer Center, New York, New York From the Loyola University Stritch School of Medicine, Maywood; Edward Hospital, Naperville, IL; University of Michigan, Ann Arbor, MI; and University of California at Davis, Davis, CA. 2The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. Lombardi Comprehensive Cancer Center at Georgetown University, Washington, DC; Strang-Cornell Breast Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; John Wayne Cancer Institute, Santa Monica, CA; Arkansas Cancer Research Center, Little Rock, AR; and the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI From the Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, Washington, D.C. From the Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange (R.S.M.); the SWOG Statistics and Data Management Center (W.E.B., D.L.L.) and Seattle Cancer Care Alliance and University of Washington Medical Center (J.R.G., H.M.L.) — both in Seattle; Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); London Health Sciences Centre and the National Cancer Institute of Canada Clinical Trials Group, London, ON, Canada (T.A.V.); the Cancer... From the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. From the Department of Biostatistics and Bioinformatics and CALGB Statistical Center, Duke University, Durham, NC; Urologic Oncology Program, University of California at San Francisco, San Francisco, CA; Breast Oncology Program, University of Michigan; University of Chicago Cancer Research Center and the Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL; The Lank Center for Genitourinary Oncology, Department of Medical Oncology Dana-Farber Cancer Institute,... Departments of Pathology, Biostatistics, Internal Medicine, Surgery, Radiation Oncology, and Urology, and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109; Swammerdam Institute for Life Sciences, Biocentrum Amsterdam, University of Amsterdam, 1018 TV Amsterdam, The Netherlands; and Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School , Ann Arbor, MI , United States; Rogel Cancer Center, University of Michigan , Ann Arbor, MI , United States The Breast Oncology Program, Comprehensive Cancer Center, and the Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI Department of Internal Medicine, Division of Hematology/Oncology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA 6University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan Hematology/Oncology, Department of Internal Medicine; Breast Oncology Program, Comprehensive Cancer Center, University of Michigan Medical Center, Ann Arbor, Michigan 48109 Breast Oncology Program of the Comprehensive Cancer Center, and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, Michigan 48109; Division of Hematology Oncology Department of Internal Medicine University of Michigan Ann Arbor MI USA From the Department of Molecular Pathology and Taussig Cancer Center, Cleveland Clinic, Cleveland; and Cancer and Leukemia Group B, Ohio State University, Arthur James Cancer Center Hospital, Columbus, OH; Cancer Research and Biostatistics; Fred Hutchinson Cancer Research Center; and Phenopath Laboratories, Seattle, WA; Department of Pathology, University of Texas, Health Science Center at San Antonio, San Antonio, TX; Eastern Cooperative Oncology Group, Cancer Pavilion, Indiana University Medical Center... From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana–Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) — both in Canada; Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) — both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the... Breast Oncology Program Stuart B. Padnos Professor in Breast Cancer Research, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. Department of Internal Medicine, University of Michigan, Ann Arbor 1University of Michigan Rogel Cancer Center and the Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan. From the North Shore Medical Center, Salem, MA; University of Texas, M.D. Anderson Cancer Center, Houston, TX; Cancer and Leukemia Group B Statistical Center, Durham, NC; Mt Sinai Medical Center, and Memorial Sloan Kettering Cancer Center, New York; North Shore University Hospital, Manhasset, NY; University of California at San Francisco, San Francisco, CA; and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. 1Breast Oncology Program of the University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.; 2Comphrehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. 2University of Michigan Rogel Cancer Center, Ann Arbor, Michigan.; 5Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan. 1Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, Michigan. Ann Arbor, Michigan. From the Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC. From the Breast Cancer and Development Therapeutic ProgramsLombardi Cancer Center, Georgetown University Medical Center, Georgetown University, Washington, DC; Dana-Farber Cancer Institute, Boston, MA; University of Chicago Medical Center, Chicago, IL; Duke University Medical Center, Durham, NC; and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD. Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Health and Hospital System, 6312 Cancer Center University of Michigan, 1500 Medical Center Drive, 48109, Ann Arbor, MI, USA. [email protected]. University of Michigan Rogel Cancer Center, Ann Arbor, MI [email protected]. From the Lank Center for Genitourinary Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA; Statistical Center, Cancer and Leukemia Group B, Duke University Medical Center, Durham, NC; Lombardi Cancer Center, Georgetown University Medical Center, Washington DC; University of Chicago Medical Center, Chicago, IL; and University of California San Francisco Comprehensive Cancer Center, San Francisco, CA. Lisa M. McShane, Biometric Research Branch and Cancer Diagnosis Program, National Cancer Institute, Bethesda, MD; and Daniel F. Hayes, Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. 1Breast Cancer Program,; 2Departments of Oncology, Internal Medicine University of Michigan Ann Arbor MI USA From the Yale Cancer Center, New Haven, CT; Duke University, Durham; University of North Carolina, Chapel Hill, NC; University of Colorado, Denver, CO; North Shore Hospital Center, Long Island; Memorial Sloane-Kettering Cancer Center, New York, NY; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; University of Michigan, Ann Arbor, MI; Cancer and Leukemia Group B Central Office, Chicago, IL; and Washington University, St Louis, MO. Julie M. Vose, University of Nebraska, Omaha, NE; Laura A. Levit, Patricia Hurley, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Carrie Lee, University of North Carolina at Chapel Hill, Chapel Hill, NC; Michael A. Thompson, Aurora Health Care, Milwaukee, WI; Teresa Stewart, New Mexico Cancer Care Alliance, Albuquerque, NM; Janie Hofacker, Association of American Cancer Institutes, Pittsburgh, PA; and Daniel F. Hayes, University of Michigan, Ann Arbor, MI. Division of Hematology and Oncology Department of Internal Medicine University of Michigan Medical School Ann Arbor MI USA; Rogel Cancer Center Michigan Medicine University of Michigan Ann Arbor MI USA Department of Internal Medicine; Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States Pacific Northwest National Laboratory, 902 Battelle Boulevard, P7-56, Richland, Washington 99354, Breast Oncology Program, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109, and University of Michigan Medical School, A510 MSRB I, Ann Arbor, Michigan 48109 From the University of Texas M.D. Anderson Cancer Center, and Baylor College of Medicine; Houston, TX; Dana-Farber Cancer Institute, Boston, MA; Georgetown University, Washington, DC; Hematology/Oncology Consultants, Columbus, OH; Ligand Pharmaceuticals Inc, San Diego; University of California Los Angeles, Los Angeles; University of California San Francisco, San Francisco, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Arkansas for Medical Sciences, Little Rock, AR; University of... From the Roswell Park Cancer Institute, Department of Cancer Prevention and Control, Buffalo, NY; Southwest Oncology Group Statistical Center, Seattle, WA; The Sidney Kimmel Cancer Center, San Diego; The Angeles Clinic and Research Institute, Santa Monica, CA; University of Arizona Cancer Center, Tucson, AZ; University of Texas Health Science Center at San Antonio, San Antonio; Baylor College of Medicine, Houston, TX; University of Michigan Medical Center, Ann Arbor, MI; University of Arkansas for... Breast Cancer Program, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis;Breast Oncology Program, University of Michigan, Ann Arbor, Mich;Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Md;Roche Molecular Diagnostics, Pleasanton, Calif. Authors' Affiliations: 1Department of Cancer Prevention and Control, Roswell Park Cancer Institute; 2Department of Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, New York; 3PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea; 4Southwest Oncology Group Statistical Center, Seattle, Washington; 5Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine, Maywood, Illinois; 6Clinical Trials Office, University of Arizona Cancer Center, Tucson, Arizona; 7Breast Oncology Program, 6312 CCGC, University of Michigan Medical Center, Ann Arbor, Michigan; 8Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; 9University of Arkansas for Medical Sciences, Little Rock, Arkansas; 10The Angeles Clinic and Research Institute, Santa Monica, California; 11Heartland Cancer Research CCOP, Missouri Baptist Medical Center, St. Louis, Missouri; 12Department of Molecular University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5940;; Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, 6312 CCC, Ann Arbor, MI 48109-5942 Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. From the University of California at San Francisco, San, Francisco, CA; Cancer and Leukemia Group B (CALGB) Statistical Center, Durham; Wake Forest University School of Medicine, Winston-Salem, NC; University of Texas M.D. Anderson Cancer, Houston; Southwest Oncology Group Operations, San, Antonio, TX; Dana-Farber Cancer Institute, Boston, MA; Eastern Cooperative Oncology Group Operations, Philadelphia, PA; North Central Cancer Treatment Group Operations, Rochester, MN; Georgetown University Medical... Intermountain Healthcare, University of Utah School of Medicine, Salt Lake City, UT; University of Michigan Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, Michigan. [email protected]. From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana–Farber Cancer Institute, Boston (R.J.G.); University of Texas, San Antonio (P.M.R.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) — both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) — both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University... From the University of Texas M.D. Anderson Cancer Center and Baylor College of Medicine, Houston, and Scott and White Memorial Hospital, Temple, TX; University of California Los Angeles–Jonsson Comprehensive Cancer Center, Los Angeles, CA; University of Alabama at Birmingham, Birmingham, AL; Memorial Sloan-Kettering Cancer Center, New York, and Roswell Park Cancer Institute, Buffalo, NY; University of Michigan, Ann Arbor, MI; WellStar Kennestone Hospital, Atlanta, GA; International Union Against Cancer... 1Department of Internal Medicine and the Comprehensive Cancer Center, University of Michigan Health and Hospital System, Ann Arbor, Michigan; From the Department of Hematology-Oncology, Palo Alto Medical Foundation, Palo Alto, California (Dr Yu); the Center for Health Insights, University of Missouri, Kansas City (Dr Hoffman); and the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor (Dr Hayes). Mark R. Somerfield, Kari Bohlke, Kaitlin Einhaus, Robert S. Miller, Thomas K. Oliver, and Eduardo Ortiz, American Society of Clinical Oncology, Alexandria; Neelima Denduluri, U.S. Oncology Network, Virginia Cancer Specialists, Arlington, VA; George P. Browman, McMaster University, Hamilton, Ontario; University of British Columbia, Vancouver, British Columbia, Canada; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Alok A. Khorana, Cleveland Clinic, Cleveland, OH;... From the Division of Hematology/Oncology, Department of Medicine, University of Florida Shands Cancer Center, Gainesville, FL; Diagnostics Evaluation Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD; Cancer Policy and Clinical Affairs, American Society of Clinical Oncology; Colorectal Cancer Coalition, Alexandria, VA; Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson... 7University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor Karen M. Winkfield, Wake Forest Baptist Medical Center, Winston-Salem, NC; Christopher R. Flowers, Winship Cancer Institute, Emory University; Otis W. Brawley, American Cancer Society, Atlanta, GA; Jyoti D. Patel, University of Chicago, Chicago; Patricia Robinson, Loyola University Medical Center, Maywood, IL; Gladys Rodriguez, South Texas Oncology and Hematology, San Antonio, TX; Amit Agarwal, University of Arizona, Tucson, AZ; Lori Pierce and Daniel F. Hayes, University of Michigan, Ann Arbor, MI;... Division of Hematology/Oncology University of Michigan Comprehensive Cancer Center Ann Arbor MI USA University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA From the Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA; Ohio State University, Columbus, OH; Maine Center for Cancer Medicine, Portland, ME; The Liposome Company, Inc, Princeton, NJ; and the Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC. Antonio C. Wolff, the Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; Ann A. Lazar, University of California San Francisco, San Francisco, CA; Igor Bondarenko, Municipal Clinical Hospital #4, State Medical Academy, Dnepropetrovsk, Ukraine; August M. Garin, Russian Oncological Research Center, Moscow, Russia; Stephen Brincat, Sir Paul Boffa Hospital, Floriana, Malta; Louis Chow, UNIMED Medical Center, Wan Chai, Hong Kong; Yan Sun, Cancer Hospital, Chinese Academy of Medical Sciences,... University of Michigan, Ann Arbor From the Winship Cancer Institute at Emory University, Atlanta (K.K.); Southwest Oncology Group Statistics and Data Management Center (W.E.B., D.L.L., J.M.) and the University of Washington School of Medicine–Seattle Cancer Care Alliance (J.R.G.) — both in Seattle; the University of Texas M.D. Anderson Cancer Center, Houston (F.M.-B., D.T., G.N.H.); Loyola University Chicago, Maywood, IL (K.S.A.); the University of Michigan, Ann Arbor (D.F.H., A.F.S.); Dana–Farber Cancer Institute, Boston (N.U.L.); Mayo... From Good Samaritan Hospital, Los Angeles, Calif (Dr Fitzgibbons); Vanderbilt University Medical Center, Nashville, Tenn (Drs Page and Simpson); University of Vermont Medical Center, Burlington, Vt (Dr Weaver); Evanston Hospital, Evanston, Ill (Dr Thor); Baylor College of Medicine, Houston, Tex (Drs Allred and Clark); Palos Community Hospital, Palos Heights, Ill (Dr Ruby); Mount Sinai Hospital, T Jason D. Merker and Maximilian Diehn, Stanford University School of Medicine; Stanford, CA; Geoffrey R. Oxnard, Dana Farber Cancer Institute and Harvard Medical School; Neal Lindeman, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Carolyn Compton, Arizona State University, Tempe, AZ; Patricia Hurley, Richard L. Schilsky, Thomas K. Oliver, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Alexander J. Lazar and Apostolia M. Tsimberidou, The University of... a University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH; University of Michigan Medical Center, Ann Arbor, MI; and American Society of Clinical Oncology, Alexandria, VA 16Department of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. Breast Oncology Program,University of Michigan Comprehensive Cancer Center, Ann Arbor 48109, USA. [email protected] University of Michigan Comprehensive Cancer Center; and University of Michigan, Ann Arbor, MI William Beaumont Hospital, Royal Oak; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI University of Michigan Rogel Cancer Center Ann Arbor MI USA Authors' Affiliations: Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Michigan Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE. From the University of Michigan Rogel Cancer Center, Ann Arbor. University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA From the Yale University School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT; University of Colorado Health Sciences Center, Denver, CO; Duke University Medical Center, Durham; University of North Carolina, Chapel Hill, NC; Monter Cancer Center of North Shore University Hospital, Lake Success; Memorial Sloan-Kettering Cancer Center, New York, NY; University of California San Francisco, CA; University of Vermont, Burlington, VT; University of Texas M.D. Anderson Cancer Center, Houston... From Intermountain Healthcare, University of Utah School of Medicine, Salt Lake City, UT; Washington University School of Medicine, St Louis, MO; American Society of Clinical Oncology, Alexandria, VA; University of Michigan Comprehensive Cancer Center, University of Michigan Health System; St Joseph Mercy Hospital; Gemini Group, Ann Arbor; Advanced Diagnostics Laboratory, Redford, MI; Presbyterian Hospital, Charlotte, NC; Indiana University, Bloomington, IN; St Jude Medical Center, Fullerton, CA;... Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Julie Vose, University of Nebraska Medical Center, Omaha, NE Authors' Affiliations: 1 Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York;, 2Southwest Oncology Group Statistical Center, Seattle, Washington;, 3Loyola University Chicago Stritch School of Medicine, Maywood, Illinois;, 4PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea, 5University of Arizona Cancer Center, Tucson, Arizona;, 6University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan;, 7University of Texas Health Science Center at San Antonio, San Antonio, Texas;, 8University of Arkansas for Medical Sciences, Little Rock, Arkansas;, 9The Angeles Clinic and Research Institute, Santa Monica, California;, 10Heartland Cancer Research CCOP, Missouri Baptist Medical Center, St. Louis, Missouri;, 11Baylor College of Medicine, Houston, Texas;, 12The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; and, 13University of Texas M.D. Anderson Cancer Center, Houston, Texas†Deceased Jason D. Merker and Maximilian Diehn, Stanford University School of Medicine; Stanford, CA; Geoffrey R. Oxnard, Dana Farber Cancer Institute and Harvard Medical School; Neal Lindeman, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Carolyn Compton, Arizona State University, Tempe, AZ; Patricia Hurley, Richard L. Schilsky, Thomas K. Oliver, and Suanna S. Bruinooge, American So Department of Internal Medicine, Breast Oncology Program of the Comprehensive Cancer Center, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109-5942, USA. [email protected]. From the Lineberger Comprehensive Cancer Center; Department of Medicine; Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University School of Medicine, Durham, NC; University of Kansas Medical Center, Kansas City, KS; Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY; University of California at San Francisco, San Francisco... 1Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. The University of Michigan Rogel Cancer Center, Ann Arbor, MI University of Michigan Rogel Cancer Center Ann Arbor MI USA; Department of Internal Medicine, Division of Hematology/Oncology University of Michigan Medical School Ann Arbor MI USA Authors' Affiliations: 1University of Michigan, Ann Arbor, Michigan; 2The Methodist Hospital Research Institute; 3Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas; 4King's College London School of Medicine, London, United Kingdom; 5The Ohio State University, Columbus, Ohio; 6Dana-Farber Cancer Institute, Boston, Massachusetts; and 7Weill Cornell Medical School, New York, New York Authors' Affiliation: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 1Internal Medicine, Departments of b Comprehensive Cancer Center Breast Oncology Program , The University of Michigan , Ann Arbor, MI, USA; f Department of Internal Medicine , The University of Michigan , Ann Arbor, MI, USA Department of Internal Medicine, Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Texas Oncology, Dallas, TX; Massimo Cristofanilli, Thomas Jefferson University–Kimmel Cancer Center, Philadelphia, PA; Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN;... Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; From The University of Texas M.D. Anderson Cancer Center, Houston, TX; The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The Cleveland Clinic, Cleveland, OH; Washington University, St Louis, MO; University of Arizona, Phoenix, AZ; and Immunicon Corporation, Huntingdon Valley, PA Breast Oncology Program University of Michigan Comprehensive Cancer Center Ann Arbor Michigan Department of Internal Medicine, University of Michigan, Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA, Tel.: +1 734 615 6725; Fax: +1 734 615 3947;; Breast Oncology Program, University of Michigan, Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA 1Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan. University of Michigan Rogel Cancer Center, Ann Arbor MI 1Breast Oncology Program, Comprehensive Cancer Center, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA |
Incoming Links
Showing number of triples: 1 to 474 of 474.